Fiche centre
Sanatorio Parque ( Site 0205)
Rosario — Argentina
Essais liés2clinical trials
VilleRosariolocalisation
PaysArgentinalocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT06312137
Essais cliniques associés
2| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Sacituzumab Tirumotecan | Cancer | Phase 3 | NCT06312137 | TroFuse-019 — A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019) | RECRUITING |
| MK-6194 | Lupus | Phase 2 | NCT06161116 | Efficacy and Safety of MK-6194 in Adult Participants With Systemic Lupus Erythematosus (MK-6194-006) | TERMINATED |